Key result
Inhibition or deficiency of platelet P2Y12 receptors significantly reduced thrombus size and increased embolization events on ruptured atherosclerotic plaques under high shear flow conditions.
Why the study?
Does P2Y12 inhibition with ticagrelor or cangrelor reduce thrombus size and improve stability on ruptured atherosclerotic plaques under high shear flow?
Population
Apoe-/- mice on C57BL/6 background fed a Western-type diet for 18-20 weeks, P2Y12-deficient mice, wild-type…
Comparison
P2Y12 inhibition via ticagrelor or cangrelor, or… vs Vehicle solution or wild-type/control conditions.
Design
Preclinical
Authors
Loading...
P2Y12 inhibition may alter thrombus dynamics on ruptured plaques; hypothesis-generating and should not change practice pending human data.
Does P2Y12 inhibition with ticagrelor or cangrelor reduce thrombus size and improve stability on ruptured atherosclerotic plaques under high shear flow?
p-value: p=<0.05
P2Y12 receptors play a crucial role in stabilizing thrombi on ruptured atherosclerotic plaques specifically under high shear flow conditions, providing mechanistic insight into the efficacy of P2Y12 inhibitors like ticagrelor.
Nergiz‐Unal et al. (2010) studied Atherothrombosis. P2Y12 inhibitors (ticagrelor and cangrelor) vs. Vehicle was evaluated on Thrombus size and stability (embolization events) (p=<0.05). Inhibition or deficiency of platelet P2Y12 receptors significantly reduced thrombus size and increased embolization events on ruptured atherosclerotic plaques under high shear flow conditions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: